Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Miele

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
BMC Cancer|August 7, 2009
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver diseaseJoe Gray, Dipankar Chattopadhyay, Gary S Beale, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 16, 2013
A phase II study of sunitinib in advanced hepatocellular carcinomaCarlo Barone, Michele Basso, Marco Biolato, et al.
The International Journal of Biological Markers|September 2, 2017
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical settingLuca Miele, Teresa De Michele, Giuseppe Marrone, et al.
Plos One|February 6, 2014
Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver diseaseSalvatore Petta, Luca Miele, Elisabetta Bugianesi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 30, 2023
Urinary lithogenic profile of patients with non-alcoholic fatty liver diseaseMatteo Bargagli, Antonio Liguori, Cecilia Napodano, et al.
Clinical Endocrinology|May 17, 2011
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndromeMaria F Gangale, Luca Miele, Antonio Lanzone, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 22, 2009
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver diseaseLuca Miele, Alessandra Forgione, Giuseppe La Torre, et al.
Biomedicines|January 25, 2025
Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD CohortAntonio Liguori, Giorgio Esposto, Maria Elena Ainora, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|July 15, 2020
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLDPaola Dongiovanni, Marica Meroni, Salvatore Petta, et al.
Cancers|October 18, 2019
Platelets and Hepatocellular Cancer: Bridging the Bench to the ClinicsQuirino Lai, Alessandro Vitale, Tommaso M Manzia, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
BMC Cancer|August 7, 2009
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver diseaseJoe Gray, Dipankar Chattopadhyay, Gary S Beale, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 16, 2013
A phase II study of sunitinib in advanced hepatocellular carcinomaCarlo Barone, Michele Basso, Marco Biolato, et al.
The International Journal of Biological Markers|September 2, 2017
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical settingLuca Miele, Teresa De Michele, Giuseppe Marrone, et al.
Plos One|February 6, 2014
Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver diseaseSalvatore Petta, Luca Miele, Elisabetta Bugianesi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 30, 2023
Urinary lithogenic profile of patients with non-alcoholic fatty liver diseaseMatteo Bargagli, Antonio Liguori, Cecilia Napodano, et al.
Clinical Endocrinology|May 17, 2011
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndromeMaria F Gangale, Luca Miele, Antonio Lanzone, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 22, 2009
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver diseaseLuca Miele, Alessandra Forgione, Giuseppe La Torre, et al.
Biomedicines|January 25, 2025
Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD CohortAntonio Liguori, Giorgio Esposto, Maria Elena Ainora, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|July 15, 2020
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLDPaola Dongiovanni, Marica Meroni, Salvatore Petta, et al.
Cancers|October 18, 2019
Platelets and Hepatocellular Cancer: Bridging the Bench to the ClinicsQuirino Lai, Alessandro Vitale, Tommaso M Manzia, et al.
Pageof 18